US President Donald Trump's decision to impose a 100 per cent tariff on branded and patented pharmaceutical imports from October 1 has put the spotlight on India’s pharmaceutical exports, a sector ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback